Philip A. Routledge

4.1k citations
91 papers · 2.8k indexed · 1 hit paper · h-index 26
Topics
Pharmaceutical Practices and Patient Outcomes (13 papers)Health Systems, Economic Evaluations, Quality of Life (10 papers)Poisoning and overdose treatments (10 papers)

In The Last Decade

Philip A. Routledge

88 papers receiving 2.6k citations

Hit Papers

Managing the challenge of chemically reactive metabolites...20112026201620212011100200300

Peers

Philip A. Routledge
Comparison fields: 5 of 144
  • Pharmacology 564
  • Toxicology 508
  • Geriatrics and Gerontology 465
  • Pediatrics, Perinatology and Child Health 431
  • Pharmacology 374
Replace Staffan Hägg with:
Staffan Hägg Sweden
Bernard Bégaud France
Manuel Haschke Switzerland
John R. Horn United States
J. Feely Ireland
Annie Fourrier‐Réglat France
Anna K. Jönsson Sweden
Andrew Scott United Kingdom
Annalisa Capuano Italy
Elisabetta Poluzzi Italy
Philip A. Routledge relative to Staffan Hägg Sweden Staffan Hägg's profile →
Citations per field
00.5×1.5×
Staffan Hägg · 1×
Citations per year

Countries citing papers authored by Philip A. Routledge

Since Specialization
Citations

This map shows the geographic impact of Philip A. Routledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Routledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Routledge more than expected).

Fields of papers citing papers by Philip A. Routledge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Routledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Routledge. The network helps show where Philip A. Routledge may publish in the future.

Co-authorship network of co-authors of Philip A. Routledge

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Routledge. A scholar is included among the top collaborators of Philip A. Routledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Routledge. Philip A. Routledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 1
3 6
4 8
5 3
6 10
7
Managing the challenge of chemically reactive metabolites in drug developmentbreakdown →
338
8 26
9 57
10 29
11 1
12 21
13 341
14 29
15 27
16 9
17 30
18 34
19 19
20 3

About Philip A. Routledge

Philip A. Routledge is a scholar working on Geriatrics and Gerontology, Toxicology and Pharmacology, having authored 91 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (13 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Poisoning and overdose treatments (10 papers). The work is most often cited by research in Toxicology (508 citations), Geriatrics and Gerontology (465 citations) and Pharmacology (564 citations). Philip A. Routledge has collaborated with scholars based in United Kingdom, United States and Iran. Frequent co-authors include David G. Shand, M. S. O'Mahony, Ken Woodhouse, Alison Blenkinsopp, Patricia Wilkie, Jonathan Hewitt, Ben Carter, Sarah Damery, Robert Grieve and Sheila Greenfield. Their work appears in journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026